Andrew R Pachner Selected Research

Monoclonal Antibodies

12/2015

The effect of B-cell depletion in the Theiler's model of multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew R Pachner Research Topics

Disease

18	Multiple Sclerosis 01/2021 - 11/2003
6	Inflammation (Inflammations) 01/2021 - 09/2002
6	Infections 01/2017 - 07/2005
5	Demyelinating Diseases (Demyelinating Disease) 05/2019 - 03/2011
2	Neuroinflammatory Diseases 01/2019 - 02/2016
2	Relapsing-Remitting Multiple Sclerosis 12/2017 - 07/2010
2	Virus Diseases (Viral Diseases) 12/2017 - 12/2015
2	Persistent Infection 12/2015 - 06/2005
2	Lyme Neuroborreliosis 06/2005 - 03/2005
1	Disease Susceptibility (Diathesis) 01/2020
1	Nervous System Diseases (Neurological Disorders) 11/2019
1	Disease Progression 12/2017
1	Encephalomyelitis (Myeloencephalitis) 12/2017
1	Spinal Cord Diseases 01/2016
1	Chronic Disease (Chronic Diseases) 12/2015
1	Communicable Diseases (Infectious Diseases) 12/2015
1	Crohn Disease (Crohn's Disease) 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Vasculitis (Vasculitides) 12/2011
1	Vocal Cord Paralysis 12/2011
1	Neuromyelitis Optica (Devic's Disease) 12/2011
1	Meningoencephalitis 03/2011
1	Myasthenia Gravis 07/2004
1	Lyme Disease (Disease, Lyme) 09/2002
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2002

Drug/Important Bio-Agent (IBA)

6	Interferon-betaIBA 12/2017 - 11/2003
5	Biomarkers (Surrogate Marker)IBA 10/2020 - 12/2015
5	AntibodiesIBA 01/2017 - 11/2003
4	Neutralizing AntibodiesIBA 09/2018 - 11/2008
3	ChemokinesIBA 05/2019 - 09/2002
3	Antiviral Agents (Antivirals)IBA 12/2017 - 01/2017
3	Immunoglobulin G (IgG)IBA 01/2017 - 06/2005
3	CytokinesIBA 12/2015 - 09/2002
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2005
2	Oligoclonal BandsIBA 01/2019 - 12/2011
2	Complement System Proteins (Complement)IBA 07/2005 - 12/2003
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2004 - 12/2003
2	Hematoxylin (Haematoxylon)IBA 02/2004 - 12/2003
1	AlbuminsIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	teriflunomideIBA 12/2017
1	Monoclonal AntibodiesIBA 12/2015
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2015
1	Bendamustine Hydrochloride FDA Link 01/2015
1	Natalizumab (Tysabri)FDA Link 01/2015
1	Rituximab (Mabthera)FDA Link 01/2015
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2011
1	Immunoglobulins (Immunoglobulin)IBA 03/2011
1	Immunomodulating AgentsIBA 07/2010
1	GadoliniumIBA 11/2009
1	Interferon beta-1b (Betaseron)FDA Link 11/2009
1	Glatiramer Acetate (Copaxone)FDA Link 11/2009
1	ElementsIBA 03/2009
1	Biological ProductsIBA 11/2007
1	Viral RNAIBA 04/2007
1	Therapeutic UsesIBA 02/2006
1	Complement Factor H (Factor H)IBA 07/2005
1	4,5-dibromo-2-pyrrolic acidIBA 06/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2005
1	AntigensIBA 07/2004
1	Chemotactic FactorsIBA 09/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 11/2003
1	Drug Therapy (Chemotherapy) 01/2015
1	Tracheostomy 12/2011
1	Immunotherapy 07/2004